Ethnic Differences Found for Fatty Liver Disease and Insulin Resistance

A large, population-based study showed ethnic differences in nonalcoholic fatty liver disease that may be partially related to differences in insulin resistance. Medscape Medical News

Community Pharmacy Fairness Act Of 2009 Introduced In House, USA

In an effort to permit community pharmacies to negotiate fairer contracts that benefit their patients, Reps. Anthony Weiner (D-NY) and Jerry Moran (R-KS) have introduced H.R. 1204, the Community Pharmacy Fairness Act of 2009. They are joined by 32 other bipartisan original sponsors.

Teaching Hospital Halves Its Rate Of Premature Births

UT Southwestern Medical Center’s primary adult teaching hospital has cut its rate of preterm births by more than half in the past 15 years, even as national rates are rising, researchers have found. The drop at Parkland Memorial Hospital, from 10.4 percent in 1988 to 4.

Ascenta Therapeutics Announces Positive Preliminary Results With AT-101 In Docetaxel Refractory Prostate Cancer

Ascenta Therapeutics announced positive preliminary results from its Phase II study of AT-101 in combination with docetaxel and prednisone (D/P) in men with docetaxel refractory, castrate resistant prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in Orlando, FL.

Novagali Pharma Presents Results Of Its Innovative Latanoprost Formulation For Glaucoma

Novagali Pharma, a French pharmaceutical ophthalmic company, announced the results of its first set of data pertaining to Nova21027, its innovative BAK-free latanoprost formulation for glaucoma.

Amicus Therapeutics Suspends Enrollment For Phase 2 Clinical Trial Of AT2220 For Pompe Disease

Amicus Therapeutics (Nasdaq: FOLD) announced that the Company has suspended enrollment for the Phase 2 clinical trial of its investigational drug AT2220 (1-deoxynojirimycin HCI) for the treatment of Pompe Disease and that it has received verbal notice from the U.S. Food and Drug Administration (FDA) that the trial is on clinical hold.

NOVAVAX Announces Preclinical Study Results For A Respiratory Syncytial Virus (’RSV’) Vaccine Candidate Directed Against The Fusion (F) Protein

Novavax, Inc. (Nasdaq: NVAX) announced results from a preclinical study of a Respiratory Syncytial Virus (”RSV”) vaccine candidate directed against the viral fusion (F) protein. The virus utilizes the F protein to fuse with cells in the respiratory tract and cause illness. Novavax’s RSV-F VLPs were made using a proprietary matrix (i.e., “core”) protein [...]

News From The Journal Of The American Society Of Plastic Surgeons March 2009

Measuring a Woman’s Measurements New web-based research has quantified the attractiveness of the female form. Using morphing software, German researchers manipulated the features of one woman into 243 variations with differing leg lengths, weights, bust sizes, and hip and waist widths. Then more than 34,000 people judged the attractiveness of the images.

How Male, Female Police Officers Manage Stress May Accentuate Stress On The Job

When male police officers need to de-stress, they might trade war stories — but likely not with their female colleagues. But the guys don’t necessarily have it easy. They are often discouraged from showing emotion when dealing with stress and are expected to uphold the overtly masculine idea of what it means [...]

Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen

Review treatment options for patients with new onset, severe, and recurrent C difficile infection.